Oura is on an acquisition spree.
What’s happening: The smart ring maker is buying Galen AI, an AI-powered health companion that unifies medical records, labs, medications, and wearable data.
Backed by Y Combinator, Galen’s early-stage, always-on healthcare assistant turns fragmented health data into personalized insights. Integrating the team and tech, Oura is accelerating its pursuit of longitudinal, context-aware guidance.
Deal flow. It’s the latest in a string of acquisitions as Oura expands beyond hardware into a full-stack health platform.
- In 2024, it bought Veri, expanding into metabolic health and CGM-driven nutrition.
- Weeks later, it acquired Sparta Science, adding performance analytics and injury risk modeling.
- More recently, it added Doublepoint’s gesture-based tech, unlocking ambient, screenless control.
One stop. With 5.5M+ rings sold and a $11B valuation, Oura is assembling the parts for a more connected, personalized health system — an end-goal chased by the industry’s biggest players.
Building its own hardware-centric hub, WHOOP recently raised $575M, while Function Health is vertically integrating across labs, diagnostics, and AI. At the same time, data aggregation is becoming a battleground, with OpenAI, Anthropic, and Perplexity pushing into healthcare interfaces and infrastructure.
Punchline: From mega-rounds to M&A to new entrants, the race to turn fragmented data, diagnostics, and AI into a real-time Personal Health OS is accelerating.
